Jefferies kept a 'Buy' call on the stock, with a target price implying an upside potential of nearly 15% from the previous ...

Its shares were listed at Rs 723 apiece on the BSE, a premium of 26.85 per cent as against the IPO issue price of Rs 570.

The company’s shares opened at Rs 723.05 on the NSE and Rs 723.10 on the BSE. This was about 27% higher than its issue price ...

Laxmi Dental shares surged by 5% on Monday, as the six-month lock-in period for specific pre-IPO shareholders concluded today, releasing a substantial portion of equity for possible trading. Catch all ...

Aadhar Housing Finance has outperformed the market by surging 20 per cent, as compared to 0.33 per cent decline in the BSE ...

The bank posted a net profit of Rs 580.9 crore for Q1 FY26, up 15.6 per cent year-on-year (YoY) from Rs 503 crore in the same ...

Following the deposit of Rs 4,843 crore, the restrictions imposed by Sebi's interim order are no longer applicable.

The asset managers will initially manage S$1.1 billion (US$856 million), and MAS is still reviewing submissions from more ...

Jane Street operated in both cash and derivatives markets as a Foreign Portfolio Investor (FPI) and as a trading member.

Anthem Biosciences shares listed on the stock exchanges on Monday with a premium of about 27 percent over it's initial public offer (IPO) price. The Rs 3,395-crore public offer was priced in the band ...

Viking Therapeutics is targeting two monster markets. David Jagielski (CRISPR Therapeutics): Biotech company CRISPR ...

Singapore's central bank will place S$1.1 billion ($856.36 million) with three asset managers as part of a S$5 billion ...